Skip Navigation


QJM Advance Access originally published online on February 22, 2006
QJM 2006 99(3):197-198; doi:10.1093/qjmed/hcl022
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/3/197    most recent
hcl022v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Karagiannis, A.
Right arrow Articles by Athyros, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karagiannis, A.
Right arrow Articles by Athyros, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Correspondence

Angioedema may not be a class side-effect of the angiotensin-converting-enzyme inhibitors

Sir,

Angioedema is a well-documented and potentially life-threatening side-effect of treatment with angiotensin-converting-enzyme (ACE) inhibitors, occurring in 0.1–0.2% of patients treated with these drugs.1 Given the growing number of patients with hypertension or heart failure treated with these drugs, and the long duration of treatment, the frequency of this complication is probably set to rise. Although most cases of angioedema occur within the first week of treatment, recent reports indicate that late-onset angioedema may be more prevalent than initially thought. This side-effect of ACE inhibitors is not an allergic reaction and can occur after many years of uneventful drug use.2 Black patients appear to be at increased risk.

We report the case of a 57-year-old Caucasian man, who was admitted to hospital because of severe dyspnoea. Clinical examination revealed intense swelling of the lips and the tongue that did not allow intubation, and emergency tracheotomy was performed to relieve airway obstruction. He had been treated for hypertension with an ACE inhibitor (ramipril 2.5 mg/day), with no side-effects over the last three years. His blood pressure was not well-controlled, however, and a family physician decided to change from ramipril to another ACE inhibitor (trandolapril 2.0 mg/day). Two days later, the patient presented with symptoms of angioedema.

Angioedema is a swelling involving the deeper layers of the skin or submucosal tissue, and usually presents as episodic attacks of swelling of the face, lips, tongue and airways, although it may also involve visceral tissues. If angioedema occurs in the upper airways it can become life-threatening; in the gastrointestinal tract it can become very painful. Two patients with recurrent severe abdominal pain, nausea and vomiting underwent three unnecessary laparotomies before the correct diagnosis was made.3 Angioedema associated with ACE inhibitors appears to be linked to the decreased degradation of bradykinin, because ACE not only converts angiotensin I to angiotensin II, but also inactivates bradykinin.4

Angioedema due to C1-inhibitor deficiency and ACE-inhibitor-related angioedema are the two forms of angioedema that result from a bradykinin-mediated increase in vasopermeability. Plasma bradykinin increases during acute angioedema in patients with hereditary C1-inhibitor deficiency, but is normal or marginally increased during remission.5 In three patients with a history of angioedema related to the use of ACE inhibitors, bradykinin levels were high during ACE inhibitor treatment.4 In another patient, the increased levels of bradykinin during an acute attack were decreased by 93% after withdrawal of the ACE inhibitor.5

The appearance of angioedema with trandolapril in a patient previously uneventfully treated with ramipril shows that angioedema may not be a class side-effect of ACE inhibitors, and that safe treatment with an ACE inhibitor does not rule out the occurrence of angioedema with another drug of the same family. Patients should be advised to report mild and self-limited episodes, and physicians must stop the ACE inhibitor immediately. If the diagnosis is missed, recurrent and more severe episodes may occur, with potentially serious consequences.

A. Karagiannis, A. Pyrpasopoulou, K. Tziomalos, M. Florentin and V. Athyros

Second Propedeutic Department of Internal Medicine Medical School Aristotle University of Thessaloniki Hippokration Hospital Thessaloniki Greece

email: astkar{at}med.auth.gr

References

1. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor induced angioedema. Incidence, prevention and management. Drug Saf 1998; 18:171–88.[CrossRef][Web of Science][Medline]

2. Agostoni A and Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001; 24:599–606.[CrossRef][Web of Science][Medline]

3. Byrne TJ, Douglas DD, Landis ME, Heppell JP. Isolated visceral angioedema: an underdiagnosed complication of ACE inhibitors? Mayo Clin Proc 2000; 75:1201–4.[Abstract]

4. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 2002; 347:621–2.[Free Full Text]

5. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998; 351:1693–7.[CrossRef][Web of Science][Medline]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/3/197    most recent
hcl022v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Karagiannis, A.
Right arrow Articles by Athyros, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karagiannis, A.
Right arrow Articles by Athyros, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?